Press "Enter" to skip to content

New patent for Genzyme Corp drug CERDELGA

0
Copyright © DrugPatentWatch. Originally published at New patent for Genzyme Corp drug CERDELGA

Annual Drug Patent Expirations for CERDELGA
Annual Drug Patent Expirations for CERDELGA

Cerdelga is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for CERDELGA.

This drug has forty-three patent family members in fifteen countries.

The generic ingredient in CERDELGA is eliglustat tartrate. One supplier is listed for this compound. Additional details are available on the eliglustat tartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Genzyme Corp drug CERDELGA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions